dc.contributor.author | Reinhardt, Hans Christian | |
dc.coverage.temporal | Fall 2008 | |
dc.date.accessioned | 2023-03-06T17:29:55Z | |
dc.date.available | 2023-03-06T17:29:55Z | |
dc.date.issued | 2008-12 | |
dc.identifier | 7.341-Fall2008 | |
dc.identifier.other | 7.341 | |
dc.identifier.other | IMSCP-MD5-81ab5efd1184a04f9b9fca12b2b7e700 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/148358 | |
dc.description.abstract | Cellular responses to DNA damage constitute one of the most important fields in cancer biology. In this class we will analyze classical and recent papers from the primary research literature to gain a profound understand of cell cycle regulation and DNA damage checkpoints that act as powerful emergency brakes to prevent cancer. This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. Many instructors of the Advanced Undergraduate Seminars are postdoctoral scientists with a strong interest in teaching. | en |
dc.language.iso | en-US | |
dc.relation.isbasedon | http://hdl.handle.net/1721.1/49423 | |
dc.rights | This site (c) Massachusetts Institute of Technology 2023. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions. | en |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 Unported | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | * |
dc.subject | DNA | en |
dc.subject | damage checkpoints | en |
dc.subject | cancer | en |
dc.subject | cells | en |
dc.subject | human cells | en |
dc.subject | exogenous | en |
dc.subject | endogenous | en |
dc.subject | checkpoints | en |
dc.subject | gene | en |
dc.subject | signaling | en |
dc.subject | cancer biology | en |
dc.subject | cancer prevention | en |
dc.subject | primary sources | en |
dc.subject | discussion | en |
dc.subject | DNA damage | en |
dc.subject | molecular | en |
dc.subject | enzyme | en |
dc.subject | cell cycle | en |
dc.subject | extracellular cues | en |
dc.subject | growth factors | en |
dc.subject | Cdk regulation | en |
dc.subject | cyclin-dependent kinase | en |
dc.subject | p53 | en |
dc.subject | tumor suppressor | en |
dc.subject | apoptosis | en |
dc.subject | signaling | en |
dc.subject | MDC1 | en |
dc.subject | H2AX | en |
dc.subject | Rad50 | en |
dc.subject | Fluorescence activated cell sorter | en |
dc.subject | Chk1 | en |
dc.subject | mutant | en |
dc.title | 7.341 The DNA Damage Response as a Target for Anti-Cancer Therapy, Fall 2008 | en |
dc.title.alternative | The DNA Damage Response as a Target for Anti-Cancer Therapy | en |
dc.type | Learning Object | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | |
dc.audience.educationlevel | Undergraduate | |
dc.subject.cip | 260911 | en |
dc.subject.cip | Oncology and Cancer Biology | en |
dc.date.updated | 2023-03-06T17:30:01Z | |